Patents by Inventor Yoshimi Homma

Yoshimi Homma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230075311
    Abstract: In one embodiment, an object of the present invention is to provide a biomarker for predicting the prognosis of a cancer patient such as a breast cancer patient. In one embodiment, the present invention relates to use of a CK2? protein or a fragment thereof in a nucleolus as a marker for predicting the prognosis of a cancer patient, a method for predicting the prognosis of a cancer patient using the marker, or a kit comprising a reagent for measuring the marker.
    Type: Application
    Filed: December 25, 2020
    Publication date: March 9, 2023
    Applicants: HOSHI GENERAL HOSPITAL, A PUBLIC INTEREST INCORPORATED FOUNDATION
    Inventors: Miwako HOMMA, Tadashi NOMIZU, Yoshimi HOMMA, Yuko HASHIMOTO, Yuichiro KIKO
  • Publication number: 20060188501
    Abstract: The present invention provides a therapeutic agent for rheumatoid arthritis which inhibits the growth of synoviocytes mediated by c-erbB-2 by clarifying the participation of c-erbB-2 in the growth of synoviocytes in rheumatoid arthritis patients and inhibiting the activation or expression of c-erbB-2.
    Type: Application
    Filed: February 24, 2006
    Publication date: August 24, 2006
    Applicant: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Yoshimi Homma, Koichiro Sato
  • Publication number: 20040214207
    Abstract: This invention relates to a diagnostic method for detecting cell-proliferating diseases characterized by analysis of the methylation level of cytosine residues in the region involved in the expression of cytokine receptor gene.
    Type: Application
    Filed: December 30, 2003
    Publication date: October 28, 2004
    Inventors: Yoshimi Homma, Noritaka Oyama, Koichiro Sato
  • Patent number: 6699666
    Abstract: This invention relates to a diagnostic method for detecting cell-proliferating diseases characterized by analysis of the methylation level of cytosine residues in the region involved in the expression of cytokine receptor gene.
    Type: Grant
    Filed: March 15, 2001
    Date of Patent: March 2, 2004
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Yoshimi Homma, Noritaka Oyama, Koichiro Sato
  • Publication number: 20030152572
    Abstract: The present invention provides a therapeutic agent for rheumatoid arthritis which inhibits the growth of synoviocytes mediated by c-erbB-2 by clarifying the participation of c-erbB-2 in the growth of synoviocytes in rheumatoid arthritis patients and inhibiting the activation or expression of c-erbB-2.
    Type: Application
    Filed: October 4, 2002
    Publication date: August 14, 2003
    Inventors: Yoshimi Homma, Koichiro Sato